Growing trend of self-administration coupled with increasing demand for minimally invasive treatments is prompting medical device manufacturers to shift their focus towards development of more reliable, accurate and easy to use auto-injectors. This Fact.MR report analyzes the expansion of
global prefilled auto-injectors market till date, and provides key insights on the growth of the market during the forecast period, 2017-2022. With self-administration of drugs taking an astral pace, scope for auto injectors to facilitate routine drug administration for critical maladies such as anaphylaxis, rheumatoid arthritis, and multiple sclerosis has favored substantial growth in prefilled auto injectors market.
Owing to fast paced lifestyle routine hospital visits remains a pertinent challenge. Adoption of user friendly prefilled auto injectors suffices targeted drug administration and eliminates frequent hospital visits. Rising mindfulness amongst patient pools on the benefits of self-administration of drugs such as precision, ease, and diminished needle pain are likely to pump in substantial growth in prefilled auto injectors market. Backed by affordable pricing and steadily rising diabetic population in mid and low income countries, emerging economies such as Asia-Pacific is estimated to be a lucrative market.
Get sample of this report at
https://www.factmr.com/connectus/sample?flag=S&rep_id=169
To sustain their leading stance amidst stiffening competition in pre-filled auto injectors market leading biopharmaceutical companies are investing in product innovations to attain diversified product portfolio. To cite an instance, Antares Pharma, an eminent pharmaceutical entity specializing in self-administered parenteral pharmaceutical products has entered into a strategic collaboration with Pfizer to develop an auto injector pen for the latter based on its flagship technologies. Developments as such are likely to incur sustained revenue pools in prefilled auto injectors market.
Online pharmacies are the largest distribution channel for prefilled auto injectors. In terms of revenue, online pharmacies currently account for around 33% share of the market. By the end of 2022, the online pharmacies distribution channel segment is estimated to reach a valuation of nearly US$ 1,500 Mn, reflecting a healthy CAGR.
Prefilled Auto Injectors Market: Overview
The prefilled auto injectors market has been analyzed in detail to offer definitive forecast insights on the market for the period 2017-22. This report is an exhaustive compilation of a detailed overview of prefilled auto injectors market and analyzes the market in terms of market dynamics, macro and micro-economic determinants that shape market growth, also shedding light on other relevant factors that direct future prospects of the market trajectory.
North America Will Continue to Spearhead the Global Prefilled Auto-Injectors Market
In terms of revenue, North America is expected to dominate the global prefilled auto-injectors market over 2022. This is primarily owing to the rising number of patients who require drug administration on regular basis. Owing to the extreme convenience of administrating insulin, prefilled auto injectors are also gaining popularity among patients suffering from diabetes in the region. The prefilled auto injectors market in North America in expected to witness a strong growth over the forecast period. Meanwhile, robust development of the healthcare sector coupled with low cost of prefilled auto-injectors is proving to be instrumental for the growth of the market in Asia-Pacific excluding Japan (APEJ). Between 2017 and 2022, the region’s market is projected to increase at an impressive CAGR of 15.9%.
Browse Full Report with TOC:
https://www.factmr.com/report/169/prefilled-auto-injectors-market
Prefilled Auto Injectors Market: Competition Landscape
Fact.MR’s report also profiled companies that are expected to remain active in the expansion of global prefilled auto injectors market through 2022, which include Becton, Dickinson and Company, Pfizer Inc., Mylan N.V., Antares Pharma, Inc., Amgen Inc., and Eli Lilly and Company.
global prefilled auto-injectors market till date, and provides key insights on the growth of the market during the forecast period, 2017-2022. With self-administration of drugs taking an astral pace, scope for auto injectors to facilitate routine drug administration for critical maladies such as anaphylaxis, rheumatoid arthritis, and multiple sclerosis has favored substantial growth in prefilled auto injectors market.
Owing to fast paced lifestyle routine hospital visits remains a pertinent challenge. Adoption of user friendly prefilled auto injectors suffices targeted drug administration and eliminates frequent hospital visits. Rising mindfulness amongst patient pools on the benefits of self-administration of drugs such as precision, ease, and diminished needle pain are likely to pump in substantial growth in prefilled auto injectors market. Backed by affordable pricing and steadily rising diabetic population in mid and low income countries, emerging economies such as Asia-Pacific is estimated to be a lucrative market.
Get sample of this report at
https://www.factmr.com/connectus/sample?flag=S&rep_id=169
To sustain their leading stance amidst stiffening competition in pre-filled auto injectors market leading biopharmaceutical companies are investing in product innovations to attain diversified product portfolio. To cite an instance, Antares Pharma, an eminent pharmaceutical entity specializing in self-administered parenteral pharmaceutical products has entered into a strategic collaboration with Pfizer to develop an auto injector pen for the latter based on its flagship technologies. Developments as such are likely to incur sustained revenue pools in prefilled auto injectors market.
Online pharmacies are the largest distribution channel for prefilled auto injectors. In terms of revenue, online pharmacies currently account for around 33% share of the market. By the end of 2022, the online pharmacies distribution channel segment is estimated to reach a valuation of nearly US$ 1,500 Mn, reflecting a healthy CAGR.
Prefilled Auto Injectors Market: Overview
The prefilled auto injectors market has been analyzed in detail to offer definitive forecast insights on the market for the period 2017-22. This report is an exhaustive compilation of a detailed overview of prefilled auto injectors market and analyzes the market in terms of market dynamics, macro and micro-economic determinants that shape market growth, also shedding light on other relevant factors that direct future prospects of the market trajectory.
North America Will Continue to Spearhead the Global Prefilled Auto-Injectors Market
In terms of revenue, North America is expected to dominate the global prefilled auto-injectors market over 2022. This is primarily owing to the rising number of patients who require drug administration on regular basis. Owing to the extreme convenience of administrating insulin, prefilled auto injectors are also gaining popularity among patients suffering from diabetes in the region. The prefilled auto injectors market in North America in expected to witness a strong growth over the forecast period. Meanwhile, robust development of the healthcare sector coupled with low cost of prefilled auto-injectors is proving to be instrumental for the growth of the market in Asia-Pacific excluding Japan (APEJ). Between 2017 and 2022, the region’s market is projected to increase at an impressive CAGR of 15.9%.
Browse Full Report with TOC:
https://www.factmr.com/report/169/prefilled-auto-injectors-market
Prefilled Auto Injectors Market: Competition Landscape
Fact.MR’s report also profiled companies that are expected to remain active in the expansion of global prefilled auto injectors market through 2022, which include Becton, Dickinson and Company, Pfizer Inc., Mylan N.V., Antares Pharma, Inc., Amgen Inc., and Eli Lilly and Company.
Comments
Post a Comment